HomeOCX • NASDAQ
add
OncoCyte Corp
Previous close
$2.79
Day range
$2.75 - $2.98
Year range
$1.92 - $4.75
Market cap
79.79M USD
Avg Volume
44.87K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 2.14M | 1,114.77% |
Operating expense | 7.25M | 27.01% |
Net income | -6.67M | 26.93% |
Net profit margin | -312.02 | 93.98% |
Earnings per share | -0.23 | 67.02% |
EBITDA | -5.43M | 0.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 31.03M | 456.27% |
Total assets | 60.36M | -14.95% |
Total liabilities | 50.14M | -7.24% |
Total equity | 10.22M | — |
Shares outstanding | 28.60M | — |
Price to book | 7.75 | — |
Return on assets | -31.01% | — |
Return on capital | -581.99% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -6.67M | 26.93% |
Cash from operations | -5.86M | -52.95% |
Cash from investing | -307.00K | -1,179.17% |
Cash from financing | 28.56M | — |
Net change in cash | 22.39M | 681.03% |
Free cash flow | -3.35M | -113.86% |
About
Founded
2009
Headquarters
Website
Employees
48
